Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF

C Deng, J Zhu, J Yuan, Y Xiang, L Dai - Neurochemical Research, 2020 - Springer
Pramipexole (PPX) is a common drug for the treatment of Parkinson's disease. However, the
mechanism allows PPX in the progression of Parkinson's disease remains largely unknown …
被引用次数：21 相关文章

[引用][C] Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF

C Deng, J Zhu, J Yuan, Y Xiang, L Dai - Neurochemical Research, 2019 - cir.nii.ac.jp
Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF

C Deng, J Zhu, J Yuan, Y Xiang… - Neurochemical …, 2020 - pubmed.ncbi.nlm.nih.gov
Pramipexole (PPX) is a common drug for the treatment of Parkinson's disease. However, the
mechanism allows PPX in the progression of Parkinson's disease remains largely unknown …

Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF.

C Deng, J Zhu, J Yuan, Y Xiang… - Neurochemical …, 2020 - search.ebscohost.com
Pramipexole (PPX) is a common drug for the treatment of Parkinson's disease. However, the
mechanism allows PPX in the progression of Parkinson's disease remains largely unknown …

Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF.

C Deng, J Zhu, J Yuan, Y Xiang, L Dai - Neurochemical Research, 2019 - europepmc.org
Pramipexole (PPX) is a common drug for the treatment of Parkinson's disease. However, the
mechanism allows PPX in the progression of Parkinson's disease remains largely unknown …

Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF

C Deng, J Zhu, Y Junlan, Y Xiang… - Neurochemical …, 2020 - search.proquest.com
Pramipexole (PPX) is a common drug for the treatment of Parkinson's disease. However, the
mechanism allows PPX in the progression of Parkinson's disease remains largely unknown …